SCHEMBL22208261

SCHEMBL22208261

COc1nc(-c2ccccc2)cc(-c2ccccc2)c1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 5/20 1.00
MAPT P10636 5/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
TSHR P16473 1/20 0.55
ATM Q13315 1/20 0.55
ACACA Q13085 1/20 0.50
KDM4E B2RXH2 4/20 0.49
NPSR1 Q6W5P4 2/20 0.49
GAA P10253 2/20 0.49
HSD17B10 Q99714 1/20 0.49
PDCD1 Q15116 3/20 0.48
CD274 Q9NZQ7 3/20 0.48
ALDH1A1 P00352 4/20 0.47
RAB9A P51151 3/20 0.47
NPC1 O15118 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 2/20 0.47
HPGD P15428 1/20 0.47
POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29442453 1.00 SQOR (1.00) SQORMAPTMEN1KMT2ATSHR
SCHEMBL22215650 0.78 SQOR (1.00) SQORMAPTKMT2AKDM4ENPSR1
SCHEMBL28871638 0.78 SQOR (0.62) SQORMAPTMEN1KMT2AACACA
SCHEMBL20125567 0.77 SQOR (0.62) SQORMAPTMEN1KMT2ATSHR
SCHEMBL29442375 0.76 SQOR (0.62) SQORMAPTMEN1KMT2ATSHR
SCHEMBL22208347 0.76 SQOR (0.86) SQORMAPTKMT2AKDM4ENPSR1
SCHEMBL29442436 0.76 SQOR (0.86) SQORMAPTKMT2AKDM4ENPSR1
SCHEMBL10205860 0.76 MEN1 (0.72) SQORMAPTMEN1KMT2ATSHR
SCHEMBL8272283 0.75 SQOR (0.60) SQORMAPTMEN1KMT2ATSHR
SCHEMBL15483493 0.75 SQOR (0.59) SQORMAPTMEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220096450-A1 Compounds and Methods for Treating or Preventing Heart Failure DREXEL UNIVERSITY 2022-03-31 US claimed
US-20220096450-A1 Compounds and Methods for Treating or Preventing Heart Failure DREXEL UNIVERSITY 2022-03-31 US disclosed
WO-2020146636-A1 COMPOUNDS AND METHODS FOR TREATING OR PREVENTING HEART FAILURE DREXEL UNIVERSITY (US) 2020-07-16 WO disclosed
WO-2020146636-A1 COMPOUNDS AND METHODS FOR TREATING OR PREVENTING HEART FAILURE DREXEL UNIVERSITY (US) 2020-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220096450-A1 Compounds and Methods for Treating or Preventing Heart Failure SQOR, QSOX1, KEAP1 SQOR 1/4885MAPT 4525/4885MEN1 3644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.